Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in EYPT — EyePoint, Inc.

CIK 1423053 MIAMI, FL
Back to EYPT Full portfolio

Position in EYPT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$24,566,728
+$24,566,728 QoQ
Shares Held
1,905,875
Ownership
2.27%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in EYPT Over Time

Shares Held

Position Value (USD)

Derivatives in EYPT

reported options exposure · as of Mar 31, 2026
CallValue
$1,281,266
CallShares
99,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. EYPT ranks #51 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in EYPT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,281,266 99,400
2026-03-31 $24,566,728 1,905,875
2025-12-31 $1,154,664 63,200
2025-12-31 $681,471 37,300
2025-09-30 $1,255,968 88,200
2025-09-30 $682,096 47,900
2025-09-30 $30,407,939 2,135,389
2025-06-30 $879,835 93,500
2025-06-30 $586,243 62,300
2025-06-30 $22,059,015 2,344,210
2025-03-31 $329,536 60,800
2025-03-31 $12,390,602 2,286,089
2025-03-31 $428,722 79,100
2024-12-31 $627,290 84,200
2024-12-31 $18,378,151 2,466,866
2024-12-31 $268,200 36,000
2024-09-30 $11,244,749 1,407,353
2024-09-30 $332,384 41,600
2024-09-30 $720,698 90,200
2024-06-30 $1,067,490 122,700
2024-06-30 $865,650 99,500
2024-06-30 $11,784,427 1,354,532
2024-03-31 $1,808,625 87,500
2024-03-31 $28,431,936 1,375,517
2024-03-31 $1,969,851 95,300
2023-12-31 $11,527,268 498,800
2023-12-31 $1,049,194 45,400
2023-12-31 $28,362,393 1,227,278
2023-09-30 $232,509 29,100
2023-09-30 $8,461,785 1,059,047
2023-09-30 $461,023 57,700
2023-06-30 $63,510 7,300
2023-06-30 $112,230 12,900
2023-06-30 $7,375,537 847,763
2023-03-31 $8,526 2,900
2023-03-31 $2,698,966 918,016
2023-03-31 $13,818 4,700
2022-12-31 $21,000 6,000
2022-12-31 $1,956,108 558,888
2022-12-31 $31,500 9,000
2022-09-30 $162,155 20,500
2022-09-30 $3,471,476 438,872
2022-06-30 $8,192,803 1,041,017
2022-06-30 $142,447 18,100
2022-03-31 $17,864,096 1,470,296
2022-03-31 $376,650 31,000
2021-12-31 $17,983,166 1,469,213
2021-12-31 $816,408 66,700
2021-09-30 $509,538 48,900
2021-09-30 $9,861,737 946,424

Report a Problem

Category
Description
Email (optional, for follow-up)